Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 63.10%169.47M | 89.59%137.74M | 8.01%536.82M | 132.05%224.87M | 20.46%135.4M | -25.73%103.91M | -49.33%72.65M | 35.97%497.03M | -14.41%96.9M | 10.73%112.4M |
| Cost of revenue | 67.82%121.51M | 98.80%97.29M | -2.66%387.28M | 149.24%168.06M | 15.88%97.89M | -38.89%72.4M | -60.44%48.94M | 32.38%397.86M | -27.50%67.43M | -0.83%84.47M |
| Gross profit | 52.26%47.97M | 70.58%40.45M | 50.80%149.54M | 92.74%56.81M | 34.30%37.51M | 47.08%31.5M | 20.41%23.71M | 52.58%99.16M | 45.77%29.48M | 71.07%27.93M |
| Operating expense | 29.52%19.52M | 48.95%15.93M | 52.85%71.67M | 97.00%29.89M | 29.71%15.63M | 46.29%15.07M | 18.56%10.7M | 44.54%46.89M | 62.49%15.17M | 38.53%12.05M |
| Selling and administrative expenses | 29.52%19.52M | 48.95%15.93M | 53.17%69.81M | 97.00%29.89M | 29.71%15.63M | 46.29%15.07M | 18.56%10.7M | 40.48%45.58M | 62.49%15.17M | 38.53%12.05M |
| -Selling and marketing expense | 68.10%1.29M | 107.63%1.31M | 61.95%4.11M | 90.78%1.24M | 17.09%1.47M | 269.23%768K | 26.81%629K | 49.71%2.54M | 84.42%651K | 133.40%1.26M |
| -General and administrative expense | 27.45%18.23M | 45.28%14.62M | 52.65%65.7M | 97.28%28.65M | 31.18%14.16M | 41.69%14.3M | 18.08%10.07M | 39.97%43.04M | 61.62%14.52M | 32.27%10.79M |
| Other operating expenses | ---- | ---- | 41.75%1.86M | ---- | ---- | ---- | ---- | --1.32M | ---- | ---- |
| Operating profit | 73.12%28.45M | 88.36%24.52M | 48.96%77.86M | 88.21%26.92M | 37.78%21.88M | 47.82%16.43M | 21.98%13.02M | 60.60%52.27M | 31.43%14.3M | 108.18%15.88M |
| Net non-operating interest income (expenses) | -55.19%-4.01M | -62.33%-4.03M | -53.52%-12.12M | -59.72%-4.31M | -34.60%-2.74M | -51.02%-2.58M | -67.68%-2.49M | -127.10%-7.89M | -312.37%-2.7M | -89.38%-2.03M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 136.97%1.39M | ---- | ---- |
| Non-operating interest expense | 55.19%4.01M | 62.33%4.03M | 53.52%12.12M | 59.72%4.31M | 34.60%2.74M | 51.02%2.58M | 67.68%2.49M | 94.29%7.89M | 117.47%2.7M | 89.38%2.03M |
| Net investment income | -18.80%190K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 990.00%654K | 1,672.09%676K | 7,266.67%2.58M | 3,655.41%2.63M | -47.83%-68K | -7.69%60K | -326.32%-43K | -180.00%-36K | -772.73%-74K | -39.39%-46K |
| Special income (charges) | 279K | 0 | ||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -612.28%-812K | ---- | ---- |
| Less:Write off | ---- | ---- | ---279K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | 67.97%1.72M | 17.07%912K | 95.81%5.57M | 220.07%2.7M | -28.76%961K | 219.06%1.02M | 270.95%779K | 265.30%2.84M | 283.04%842K | 168.19%1.35M |
| Income before tax | 79.55%26.81M | 95.88%22.08M | 57.20%74.17M | 125.80%27.93M | 32.25%20.04M | 52.49%14.93M | 19.64%11.27M | 70.10%47.18M | 62.25%12.37M | 115.70%15.15M |
| Income tax | 35.83%7.43M | 99.49%5.82M | 58.75%20.83M | 115.34%7.76M | 14.85%4.68M | 108.14%5.47M | 2.93%2.92M | 74.12%13.12M | 64.94%3.6M | 141.72%4.07M |
| Net income | 104.83%19.38M | 94.62%16.25M | 56.60%53.34M | 130.10%20.17M | 38.64%15.36M | 32.07%9.46M | 26.84%8.35M | 68.60%34.06M | 61.17%8.77M | 107.49%11.08M |
| Net income continuous operations | 104.83%19.38M | 94.62%16.25M | 56.60%53.34M | 130.10%20.17M | 38.64%15.36M | 32.07%9.46M | 26.84%8.35M | 68.60%34.06M | 61.17%8.77M | 107.49%11.08M |
| Noncontrolling interests | 144.70%646K | -26.08%377K | -2.37%1.4M | -134.65%-360K | 130.14%985K | 1,566.67%264K | 535.90%510K | 164.09%1.43M | 275.09%1.04M | 214.71%428K |
| Net income attributable to the company | 103.69%18.73M | 102.47%15.88M | 59.19%51.94M | 165.70%20.53M | 34.97%14.37M | 28.06%9.2M | 17.01%7.84M | 65.96%32.63M | 49.69%7.73M | 104.69%10.65M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 103.69%18.73M | 102.47%15.88M | 59.19%51.94M | 165.70%20.53M | 34.97%14.37M | 28.06%9.2M | 17.01%7.84M | 65.96%32.63M | 49.69%7.73M | 104.69%10.65M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 78.63%0.0234 | 83.48%0.0211 | 50.61%0.0735 | 145.22%0.0282 | 26.42%0.0201 | 21.30%0.0131 | 15.00%0.0115 | 65.42%0.0488 | 47.44%0.0115 | 103.85%0.0159 |
| Diluted earnings per share | 82.76%0.0212 | 88.24%0.0192 | 45.58%0.0658 | 143.27%0.0253 | 22.45%0.018 | 17.17%0.0116 | 3.03%0.0102 | 54.27%0.0452 | 35.06%0.0104 | 88.46%0.0147 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.